Treatment Planning Study for Microbeam Radiotherapy Using Clinical Patient Data.

Abstract

Simple SummaryMicrobeam radiotherapy is a novel dose delivery technique in radiation oncology. Preclinical studies have demonstrated preferable dose distributions with reduced damage to normal tissue but similar tumor control compared to conventional radiotherapy. For future clinical applications, realistic treatment plans for patient data are required as well as a method for comparing the spatially fractionated MRT doses with conventional broad beam doses. In this study, we performed MRT treatment planning on real patient data for relevant clinical scenarios. We successfully implemented a sophisticated dose comparison concept based on the equivalent uniform dose. For most scenarios and parameters studied, the clinical dose constraints were met. However, limitations were caused by the lack of treatment plan optimization and dose optimization. Altogether, we demonstrated the feasibility of achieving clinically acceptable MRT dose distributions based on real patient data as a primary major step towards clinical application of MRT.Microbeam radiotherapy (MRT) is a novel, still preclinical dose delivery technique. MRT has shown reduced normal tissue effects at equal tumor control rates compared to conventional radiotherapy. Treatment planning studies are required to permit clinical application. The aim of this study was to establish a dose comparison between MRT and conventional radiotherapy and to identify suitable clinical scenarios for future applications of MRT. We simulated MRT treatment scenarios for clinical patient data using an inhouse developed planning algorithm based on a hybrid Monte Carlo dose calculation and implemented the concept of equivalent uniform dose (EUD) for MRT dose evaluation. The investigated clinical scenarios comprised fractionated radiotherapy of a glioblastoma resection cavity, a lung stereotactic body radiotherapy (SBRT), palliative bone metastasis irradiation, brain metastasis radiosurgery and hypofractionated breast cancer radiotherapy. Clinically acceptable treatment plans were achieved for most analyzed parameters. Lung SBRT seemed the most challenging treatment scenario. Major limitations comprised treatment plan optimization and dose calculation considering the tissue microstructure. This study presents an important step of the development towards clinical MRT. For clinical treatment scenarios using a sophisticated dose comparison concept based on EUD and EQD2, we demonstrated the capability of MRT to achieve clinically acceptable dose distributions.